On Biostatistics and Clinical Trials

N-of-1 clinical trial is often mentioned as one of the approaches to address the challenging issues in orphan drug development. at one point...

Drug development for rare diseases is challenging, complex, but absolutely necessary. FDA has special programs to manage and encourage the d...